Overview

VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients

Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relative hypovolemia.
Phase:
Phase 2
Details
Lead Sponsor:
Vivacelle Bio